Abbott Laboratories’ Q2 results provide ‘hope’ for medical device markets, says analyst
Abbott’s Tendyne implant became the first TMVR device to gain commercial clearance in January 2020 (Credit: Abbott)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X